annual SGA:
$20.61M+$7.04M(+51.80%)Summary
- As of today (September 17, 2025), CDTX annual SGA is $20.61 million, with the most recent change of +$7.04 million (+51.80%) on December 31, 2024.
- During the last 3 years, CDTX annual SGA has risen by +$1.88 million (+10.01%).
- CDTX annual SGA is now at all-time high.
Performance
CDTX SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly SGA:
$6.50M+$323.00K(+5.23%)Summary
- As of today (September 17, 2025), CDTX quarterly SGA is $6.50 million, with the most recent change of +$323.00 thousand (+5.23%) on June 30, 2025.
- Over the past year, CDTX quarterly SGA has increased by +$1.76 million (+37.00%).
- CDTX quarterly SGA is now -11.03% below its all-time high of $7.31 million, reached on December 31, 2024.
Performance
CDTX quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SGA:
-$2.47B-$117.49M(-5.00%)Summary
- As of today (September 17, 2025), CDTX TTM SGA is -$2.47 billion, with the most recent change of -$117.49 million (-5.00%) on June 30, 2025.
- Over the past year, CDTX TTM SGA has dropped by -$2.48 billion (-16440.16%).
- CDTX TTM SGA is now -18431.29% below its all-time high of -$13.30 million.
Performance
CDTX TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, general & administrative expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
CDTX Selling, general & administrative expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +51.8% | +37.0% | -10000.0% |
| 3 y3 years | +10.0% | +59.6% | -10000.0% |
| 5 y5 years | +27.0% | +63.8% | -10000.0% |
CDTX Selling, general & administrative expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +51.8% | -11.0% | +104.4% | -59.9% | at low |
| 5 y | 5-year | at high | +51.8% | -11.0% | +104.4% | -128.7% | at low |
| alltime | all time | at high | +7479.0% | -11.0% | +2213.9% | <-9999.0% | at low |
CDTX Selling, general & administrative expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $6.50M(+5.2%) | $24.95M(+7.6%) |
| Mar 2025 | - | $6.18M(-15.4%) | $23.20M(+12.5%) |
| Dec 2024 | $20.61M(+51.8%) | $7.31M(+47.2%) | $20.61M(+23.0%) |
| Sep 2024 | - | $4.96M(+4.6%) | $16.75M(+11.0%) |
| Jun 2024 | - | $4.75M(+32.0%) | $15.09M(+11.6%) |
| Mar 2024 | - | $3.60M(+4.3%) | $13.52M(-6.0%) |
| Dec 2023 | $13.58M(-33.9%) | $3.45M(+4.5%) | $14.38M(-12.4%) |
| Sep 2023 | - | $3.30M(+3.7%) | $16.43M(-13.1%) |
| Jun 2023 | - | $3.18M(-28.6%) | $18.91M(-4.5%) |
| Mar 2023 | - | $4.46M(-18.8%) | $19.80M(-3.6%) |
| Dec 2022 | $20.55M(+9.6%) | $5.49M(-5.1%) | $20.55M(+2.5%) |
| Sep 2022 | - | $5.78M(+41.9%) | $20.04M(+6.2%) |
| Jun 2022 | - | $4.07M(-21.7%) | $18.87M(-1.5%) |
| Mar 2022 | - | $5.20M(+4.5%) | $19.16M(+2.3%) |
| Dec 2021 | $18.74M(+17.9%) | $4.98M(+8.1%) | $18.74M(+4.7%) |
| Sep 2021 | - | $4.61M(+5.4%) | $17.91M(+5.4%) |
| Jun 2021 | - | $4.37M(-8.6%) | $16.99M(+2.4%) |
| Mar 2021 | - | $4.78M(+15.3%) | $16.59M(+4.3%) |
| Dec 2020 | $15.90M(-2.1%) | $4.15M(+12.5%) | $15.90M(-1.6%) |
| Sep 2020 | - | $3.69M(-7.1%) | $16.16M(-5.2%) |
| Jun 2020 | - | $3.97M(-3.1%) | $17.04M(+2.7%) |
| Mar 2020 | - | $4.09M(-7.0%) | $16.60M(+2.2%) |
| Dec 2019 | $16.24M | $4.41M(-3.7%) | $16.24M(+5.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2019 | - | $4.57M(+29.7%) | $15.38M(+7.9%) |
| Jun 2019 | - | $3.52M(-5.6%) | $14.26M(-0.1%) |
| Mar 2019 | - | $3.73M(+5.2%) | $14.27M(+0.9%) |
| Dec 2018 | $14.14M(+9.7%) | $3.55M(+3.0%) | $14.14M(+2.3%) |
| Sep 2018 | - | $3.45M(-2.4%) | $13.82M(+2.7%) |
| Jun 2018 | - | $3.53M(-2.2%) | $13.46M(+0.8%) |
| Mar 2018 | - | $3.61M(+11.8%) | $13.35M(+3.5%) |
| Dec 2017 | $12.90M(+1.3%) | $3.23M(+4.5%) | $12.90M(+1.5%) |
| Sep 2017 | - | $3.09M(-9.8%) | $12.71M(-3.9%) |
| Jun 2017 | - | $3.42M(+8.5%) | $13.23M(+0.3%) |
| Mar 2017 | - | $3.15M(+3.7%) | $13.20M(+3.6%) |
| Dec 2016 | $12.74M(+44.1%) | $3.04M(-15.6%) | $12.74M(+5.6%) |
| Sep 2016 | - | $3.61M(+6.4%) | $12.06M(+10.7%) |
| Jun 2016 | - | $3.39M(+25.8%) | $10.89M(+11.9%) |
| Mar 2016 | - | $2.70M(+14.0%) | $9.74M(+10.2%) |
| Dec 2015 | $8.84M(+167.3%) | $2.36M(-3.2%) | $8.84M(+15.5%) |
| Sep 2015 | - | $2.44M(+9.2%) | $7.65M(+17.0%) |
| Jun 2015 | - | $2.24M(+24.4%) | $6.54M(+35.5%) |
| Mar 2015 | - | $1.80M(+52.9%) | $4.82M(+45.9%) |
| Dec 2014 | $3.31M(+1115.4%) | $1.18M(-11.5%) | $3.31M(+55.1%) |
| Sep 2014 | - | $1.33M(+154.4%) | $2.13M(+165.4%) |
| Jun 2014 | - | $522.00K(+85.8%) | $803.00K(+185.8%) |
| Mar 2014 | - | $281.00K | $281.00K |
| Dec 2013 | $272.00K | - | - |
FAQ
- What is Cidara Therapeutics, Inc. annual SGA?
- What is the all time high annual SGA for Cidara Therapeutics, Inc.?
- What is Cidara Therapeutics, Inc. annual SGA year-on-year change?
- What is Cidara Therapeutics, Inc. quarterly SGA?
- What is the all time high quarterly SGA for Cidara Therapeutics, Inc.?
- What is Cidara Therapeutics, Inc. quarterly SGA year-on-year change?
- What is Cidara Therapeutics, Inc. TTM SGA?
- What is the all time high TTM SGA for Cidara Therapeutics, Inc.?
- What is Cidara Therapeutics, Inc. TTM SGA year-on-year change?
What is Cidara Therapeutics, Inc. annual SGA?
The current annual SGA of CDTX is $20.61M
What is the all time high annual SGA for Cidara Therapeutics, Inc.?
Cidara Therapeutics, Inc. all-time high annual SGA is $20.61M
What is Cidara Therapeutics, Inc. annual SGA year-on-year change?
Over the past year, CDTX annual SGA has changed by +$7.04M (+51.80%)
What is Cidara Therapeutics, Inc. quarterly SGA?
The current quarterly SGA of CDTX is $6.50M
What is the all time high quarterly SGA for Cidara Therapeutics, Inc.?
Cidara Therapeutics, Inc. all-time high quarterly SGA is $7.31M
What is Cidara Therapeutics, Inc. quarterly SGA year-on-year change?
Over the past year, CDTX quarterly SGA has changed by +$1.76M (+37.00%)
What is Cidara Therapeutics, Inc. TTM SGA?
The current TTM SGA of CDTX is -$2.47B
What is the all time high TTM SGA for Cidara Therapeutics, Inc.?
Cidara Therapeutics, Inc. all-time high TTM SGA is -$13.30M
What is Cidara Therapeutics, Inc. TTM SGA year-on-year change?
Over the past year, CDTX TTM SGA has changed by -$2.48B (-16440.16%)